Cerebral Small Vessel Disease Progression Increases Risk of Incident Parkinsonism
- PMID: 36762437
- DOI: 10.1002/ana.26615
Cerebral Small Vessel Disease Progression Increases Risk of Incident Parkinsonism
Abstract
Objective: Cerebral small vessel disease (SVD) is associated with motor impairments and parkinsonian signs cross-sectionally, however, there are little longitudinal data on whether SVD increases risk of incident parkinsonism itself. We investigated the relation between baseline SVD severity as well as SVD progression, and incident parkinsonism over a follow-up of 14 years.
Methods: This study included 503 participants with SVD, and without parkinsonism at baseline, from the RUN DMC prospective cohort study. Baseline inclusion was performed in 2006 and follow-up took place in 2011, 2015, and 2020, including magnetic resonance imaging (MRI) and motor assessments. Parkinsonism was diagnosed according to the UK Brain Bank criteria, and stratified into vascular parkinsonism (VaP) and idiopathic Parkinson's disease (IPD). Linear mixed-effect models were constructed to estimate individual rate changes of MRI-characteristics.
Results: Follow-up for incident parkinsonism was near-complete (99%). In total, 51 (10.2%) participants developed parkinsonism (33 VaP, 17 IPD, and 1 progressive supranuclear palsy). Patients with incident VaP had higher SVD burden compared with patients with IPD. Higher baseline white matter hyperintensities (hazard ratio [HR] = 1.46 per 1-SD increase, 95% confidence interval [CI] = 1.21-1.78), peak width of skeletonized mean diffusivity (HR = 1.66 per 1-SD increase, 95% CI = 1.34-2.05), and presence of lacunes (HR = 1.84, 95% CI = 0.99-3.42) were associated with increased risk of all-cause parkinsonism. Incident lacunes were associated with incident VaP (HR = 4.64, 95% CI = 1.32-16.32).
Interpretation: Both baseline SVD severity and SVD progression are independently associated with long-term parkinsonism. Our findings indicate a causal role of SVD in parkinsonism. Future studies are needed to examine the underlying pathophysiology of this relation. ANN NEUROL 2023;93:1130-1141.
© 2023 The Authors. Annals of Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.
Similar articles
-
Cerebral small vessel disease and incident parkinsonism: The RUN DMC study.Neurology. 2015 Nov 3;85(18):1569-77. doi: 10.1212/WNL.0000000000002082. Epub 2015 Oct 7. Neurology. 2015. PMID: 26446068 Free PMC article.
-
Brain atrophy and strategic lesion location increases risk of parkinsonism in cerebral small vessel disease.Parkinsonism Relat Disord. 2019 Apr;61:94-100. doi: 10.1016/j.parkreldis.2018.11.010. Epub 2018 Nov 8. Parkinsonism Relat Disord. 2019. PMID: 30448096
-
Cerebral Small Vessel Disease Progression and the Risk of Dementia: A 14-Year Follow-Up Study.Am J Psychiatry. 2023 Jul 1;180(7):508-518. doi: 10.1176/appi.ajp.20220380. Epub 2023 Apr 19. Am J Psychiatry. 2023. PMID: 37073486
-
Parkinsonism and cerebrovascular disease.J Neurol Sci. 2022 Feb 15;433:120011. doi: 10.1016/j.jns.2021.120011. Epub 2021 Oct 6. J Neurol Sci. 2022. PMID: 34686356 Review.
-
Diffusion magnetic resonance imaging in cerebral small vessel disease.Rev Neurol (Paris). 2017 Apr;173(4):201-210. doi: 10.1016/j.neurol.2017.03.005. Epub 2017 Apr 6. Rev Neurol (Paris). 2017. PMID: 28392060 Review.
Cited by
-
Vascular Impairment, Muscle Atrophy, and Cognitive Decline: Critical Age-Related Conditions.Biomedicines. 2024 Sep 13;12(9):2096. doi: 10.3390/biomedicines12092096. Biomedicines. 2024. PMID: 39335609 Free PMC article. Review.
-
The necessity of eliminating the interference of panaxatriol saponins to maximize the preventive effect of panaxadiol saponins against Parkinson's disease in rats.J Ginseng Res. 2024 Sep;48(5):464-473. doi: 10.1016/j.jgr.2024.05.002. Epub 2024 May 14. J Ginseng Res. 2024. PMID: 39263312 Free PMC article.
-
Meso-cortical pathway damage in cognition, apathy and gait in cerebral small vessel disease.Brain. 2024 Nov 4;147(11):3804-3816. doi: 10.1093/brain/awae145. Brain. 2024. PMID: 38709856 Free PMC article.
-
Tackling vascular risk factors as a possible disease modifying intervention in Parkinson's disease.NPJ Parkinsons Dis. 2024 Mar 2;10(1):50. doi: 10.1038/s41531-024-00666-6. NPJ Parkinsons Dis. 2024. PMID: 38431725 Free PMC article. No abstract available.
-
Structural Network Efficiency Predicts Conversion to Incident Parkinsonism in Patients With Cerebral Small Vessel Disease.J Gerontol A Biol Sci Med Sci. 2024 Jan 1;79(1):glad182. doi: 10.1093/gerona/glad182. J Gerontol A Biol Sci Med Sci. 2024. PMID: 37527837 Free PMC article.
References
-
- Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010;9:689-701.
-
- Wardlaw JM, Smith C, Dichgans M. Small vessel disease: mechanisms and clinical implications. Lancet Neurol 2019;18:684-696.
-
- de Laat KF, van Norden AG, Gons RA, et al. Cerebral white matter lesions and lacunar infarcts contribute to the presence of mild parkinsonian signs. Stroke 2012;43:2574-2579.
-
- Bennett DA, Beckett LA, Murray AM, et al. Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Engl J Med 1996;334:71-76.
-
- Oveisgharan S, Yu L, Poole VN, et al. Association of White Matter Hyperintensities with Pathology and Progression of parkinsonism in aging. JAMA Neurol 2021;78:1494-1502.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
